Literature DB >> 17304034

Diagnosis of polycystic ovary syndrome.

Bradley Trivax1, Ricardo Azziz.   

Abstract

Polycystic ovary syndrome (PCOS) is a diagnosis of exclusion, with other androgen excess and ovulatory dysfunction disorders to be ruled out. There are 3 principal features of the syndrome, including hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. These features have been included in slightly different permutations in the 3 criteria currently available to diagnose PCOS, including that of the National Institutes of Health (NIH) 1990, Rotterdam 2003, and the Androgen Excess Society 2006. Overall, at least 1 in 15 women of reproductive age will be affected by PCOS, making this disorder the most common endocrine abnormality in this age group, with a health burden of over 4 billion dollars in the United States alone.

Entities:  

Mesh:

Year:  2007        PMID: 17304034     DOI: 10.1097/GRF.0b013e31802f351b

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  21 in total

Review 1.  Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women.

Authors:  Jing Zhang; Liulin Tang; Linglingli Kong; Taixiang Wu; Liangzhi Xu; Xin Pan; Guan J Liu
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

2.  Consistent ovulation may not be enough to make women healthy when approaching menopause: an update from the Study of Women's Health Across the Nation.

Authors:  Amanda A Allshouse; Alex Polotsky; Sybil Crawford; Hsiang-Yu Chen; Samar R El Khoudary; Nanette Santoro
Journal:  Menopause       Date:  2015-03       Impact factor: 2.953

Review 3.  The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis.

Authors:  Daniel Skubleny; Noah J Switzer; Richdeep S Gill; Mark Dykstra; Xinzhe Shi; Margaret A Sagle; Christopher de Gara; Daniel W Birch; Shahzeer Karmali
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

4.  Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.

Authors:  Megan M Wenner; Hugh S Taylor; Nina S Stachenfeld
Journal:  J Physiol       Date:  2011-08-08       Impact factor: 5.182

5.  Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients.

Authors:  Mahmud Shaker; Zohair I Al Mashhadani; Atheer A Mehdi
Journal:  Oman Med J       Date:  2010-10

Review 6.  Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions.

Authors:  Adina Turcu; Joshua M Smith; Richard Auchus; William E Rainey
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

7.  Greater exercise sweating in obese women with polycystic ovary syndrome compared with obese controls.

Authors:  Nina S Stachenfeld; Catherine Weikart Yeckel; Hugh S Taylor
Journal:  Med Sci Sports Exerc       Date:  2010-09       Impact factor: 5.411

8.  Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.

Authors:  M E Pall; M C Lao; S S Patel; M L Lee; D E Ghods; D W Chandler; T C Friedman
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

9.  Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin.

Authors:  Miranda Harris-Glocker; Kristin Davidson; Lynda Kochman; David Guzick; Kathleen Hoeger
Journal:  Fertil Steril       Date:  2009-09-24       Impact factor: 7.329

10.  A subpathway-based method of drug reposition for polycystic ovary syndrome.

Authors:  Hai-Ying Liu; Jian-Qiao Liu; Zi-Xin Mai; Yan-Ting Zeng
Journal:  Reprod Sci       Date:  2014-07-11       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.